ir.orchard-tx.com
Open in
urlscan Pro
2.21.20.20
Public Scan
Submitted URL: http://ir.orchard-tx.com/
Effective URL: https://ir.orchard-tx.com/
Submission: On November 08 via api from US — Scanned from IT
Effective URL: https://ir.orchard-tx.com/
Submission: On November 08 via api from US — Scanned from IT
Form analysis
0 forms found in the DOMText Content
Skip to main navigation * Investors & Media * Culture * News and Views * Contact * About * Approach * Focus * Families * Healthcare Professionals * Overview * News & Events * News & Press Releases * Events * Presentations * Financials & Filings * SEC Filings * Annual Reports * Quarterly Results * 2023 PFIC Annual Information Statement * Investor Resources * Investor Contact * Email Alerts INVESTORS & MEDIA INVESTORS & MEDIA Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment. Founded in 2015, Orchard’s roots go back to some of the first research and clinical developments involving HSC gene therapy. Our team has played a central role in the evolution of this technology from a promising scientific idea to a potentially life-transforming reality. Today, Orchard is advancing a pipeline of HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist. FIND OUT MORE ABOUT ORCHARD News & Press Releases Oct 23, 2024 Orchard Therapeutics Announces Multiple Data Presentations and Publications Oct 07, 2024 Orchard Therapeutics and Er-Kim Announce Partnership to Broaden Access to Libmeldy to Eligible Patients in Turkey and Certain Eurasian Countries Aug 28, 2024 Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Portfolio at SSIEM 2024 View all Events More events are coming soon. View all Fact Sheet More information is coming soon. Corporate Presentation More information is coming soon. Print Page Email Page Email Alerts RSS Feeds © Orchard Therapeutics plc. * About * Approach * Focus * Families * Healthcare Professionals * Investors & Media * Culture * News and Views * Contact * Privacy Policy * Cookie Policy * Terms & Conditions * Twitter * Linkedin The site uses cookies to provide you with a more responsive and personalized service. By using this site, you agree to our use of cookies as set out in our cookie notice. Please read our privacy notice and cookie notice for more information on the cookies we use and how to delete or block the use of cookies. I agree to using cookies